Stock futures were slightly up in the premarket hours of Tuesday amid a Bitcoin price decline and rising anticipation for a Federal Reserve interest rate cut at its December 9-10 meeting.
Biggest stock gainers
- MongoDB (MDB) +24% – Shares jumped after the company delivered strong Q3 results and issued a beat-and-raise outlook. For Q4, MongoDB expects revenue of $665M–$670M, well above the $639.21M consensus, and sees adjusted EPS of $1.44–$1.48 vs. the $1.30 consensus. The company also raised its FY2026 revenue forecast to $2.43B–$2.44B, up from its prior $2.34B–$2.36B range, surpassing the consensus of $2.42B.
- Credo Technology (CRDO) +18% – Shares surged after the company posted a standout FQ2, with revenue soaring 272% Y/Y and both results and guidance coming in well ahead of expectations. Credo now forecasts $335M–$345M in revenue for the upcoming quarter, far above the $247.6M analysts projected.
Biggest stock losers
- Janux Therapeutics (JANX) -44% – Shares plunged despite the company reporting positive interim Phase 1 data for its PSMA-directed TRACTr candidate JANX007 in metastatic castration-resistant prostate cancer. As of the October 15 cutoff, 109 patients had been treated across Phase 1a and Phase 1b, with the heavily pre-treated Phase 1a group showing high PSA response rates and 30% partial responses among RECIST-evaluable patients. The company highlighted encouraging anti-tumor activity, deep PSA declines, and the potential for a patient-friendly Q2W dosing schedule.